#pharmaceuticals

Collection of pharmaceuticals news, found 358 news.

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

  • 5th September 2011

-    In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

  • 16th August 2011

-Analysis evaluated efficacy and safety among three patient sub-groups        A new ...

Eli Lilly India and Lupin Announce Strategic Collaboration to Help Fight the Battle Against Diabetes

Eli Lilly India and Lupin Announce Strategic Collaboration to Help Fight the Battle Against Diabetes

  • 30th July 2011

-    Eli Lilly India (Lilly) and Lupin Limited (Lupin) today announced they have entered into a ...

Jubilant and Endo Pharmaceuticals Announce Late Stage Discovery Milestone in Oncology Program

Jubilant and Endo Pharmaceuticals Announce Late Stage Discovery Milestone in Oncology Program

  • 20th June 2011

-    Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo ...

Synthes and Lilly Sign Development and Collaboration Agreement

Synthes and Lilly Sign Development and Collaboration Agreement

  • 10th June 2011

-        Synthes, Inc. (SIX: SYST.VX) and Eli Lilly and Company (NYSE: LLY) today ...

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

  • 8th June 2011

-FDA allows use of investigational new drug for life-threatening indications     Edison ...

Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation

Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation

  • 8th June 2011

-Designation covers inherited respiratory chain diseases of the mitochondria    Edison Pharmaceuticals, ...

Ashland to Acquire International Specialty Products Inc. (ISP)

Ashland to Acquire International Specialty Products Inc. (ISP)

  • 3rd June 2011

-     Broadens Global Leadership in Specialty Chemicals     Ashland Inc. (NYSE: ...

Wes Wheeler Appointed as CEO by Marken's Board of Directors

Wes Wheeler Appointed as CEO by Marken's Board of Directors

  • 26th May 2011

-        The Marken Board of Directors is pleased to announce the appointment of Wesley ...

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

  • 31st March 2011

-    Platelet Function Testing May Be Used to Aid Patient Management    Accumetrics, ...

Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA

Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA

  • 16th March 2011

-Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended    ...

Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.

Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.

  • 3rd March 2011

-VerifyNow System to be used in Drug Developer's Clinical Studies    Accumetrics, Inc., a privately-held ...

RI projected to become global seaweed producer

RI projected to become global seaweed producer

  • 17th January 2011

Marine Affairs and Fisheries Minister Fadel Muhammad has the ambition not only to turn Indonesia into a top global ...